Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Johnson and Johnson
McKinsey
Express Scripts
Fish and Richardson
Colorcon
Citi
US Department of Justice
Fuji
Teva

Generated: August 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: rivastigmine tartrate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis
EXELON
rivastigmine tartrate
CAPSULE;ORAL020823NDANovartis Pharmaceuticals Corporation0078-0323-06100 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0323-06) > 1 CAPSULE in 1 BLISTER PACK (0078-0323-61)
Novartis
EXELON
rivastigmine tartrate
CAPSULE;ORAL020823NDANovartis Pharmaceuticals Corporation0078-0323-08500 CAPSULE in 1 BOTTLE (0078-0323-08)
Novartis
EXELON
rivastigmine tartrate
CAPSULE;ORAL020823NDANovartis Pharmaceuticals Corporation0078-0323-1530 CAPSULE in 1 BLISTER PACK (0078-0323-15)
Novartis
EXELON
rivastigmine tartrate
CAPSULE;ORAL020823NDANovartis Pharmaceuticals Corporation0078-0323-4460 CAPSULE in 1 BOTTLE (0078-0323-44)
Novartis
EXELON
rivastigmine tartrate
CAPSULE;ORAL020823NDANovartis Pharmaceuticals Corporation0078-0324-06100 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0324-06) > 1 CAPSULE in 1 BLISTER PACK (0078-0324-61)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Covington
US Department of Justice
Boehringer Ingelheim
Queensland Health
Healthtrust
Colorcon
Argus Health
McKinsey

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot